Evidence map›Paper›PMID 25158994›Full record

ArticleAge (Dordrecht, Netherlands)2014

Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K/Akt signaling to improve the effects of exercise in elderly rat hearts.

Chih-Hsueh Lin, Cheng-Chieh Lin, Wei-Jen Ting, Pei-Ying Pai, Chia-Hua Kuo, Tsung-Jung Ho, Wei-Wen Kuo, Chung-Ho Chang, Chih-Yang Huang, Wan-Teng Lin

Abstract read
In one paragraph

Article in Age (Dordrecht, Netherlands), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. The multifaceted impact of physical exercise on FoxO signaling pathways.Frontiers in cell and developmental biology · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chih-Hsueh LinDepartment of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
Cheng-Chieh Lin
Wei-Jen Ting
Pei-Ying Pai
Chia-Hua Kuo
Tsung-Jung Ho
Wei-Wen Kuo
Chung-Ho Chang
Chih-Yang Huang
Wan-Teng Lin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exercise training is considered a benefit to heart function, but the benefit in aging hearts remains unknown. Activation of the PI3K-Akt survival pathway and suppression of Fas/FADD/caspase-8 apoptotic signaling by exercise training in hearts from young subjects have been described in our previous studies. However, the mechanisms are still unclear and need to be explored in aging hearts. Thus, 18-month-old rats were used as a model and underwent swimming exercise training, resveratrol treatment (15 mg/kg/day), or exercise training with resveratrol treatment for 1 month. The results showed that heart function in each group improved. However, the 18-month-old rats in the exercise-only group experienced the slightly inevitable impact of increased TNF-α, cell apoptosis, and fibrosis. In the protein analysis, the PI3K-Akt pathway was slightly increased with exercise training and resveratrol treatment, but Sirtuin 1 (SIRT1) was only highly activated with resveratrol treatment in the aged rat hearts. Moreover, the exercise training plus resveratrol group benefited from SIRT1 and PI3K-Akt dual pathways and blocked FOXO3 accumulation. Our experimental results strongly suggest that resveratrol treatment improves the beneficial effects of exercise training in aging rat hearts.

Indexed as

Angiogenesis InhibitorsAnimalsApoptosisBiopsyBlotting, WesternCarrier ProteinsForkhead Box Protein O3Forkhead Transcription FactorsIn Situ Nick-End LabelingMyocardiumOncogene Protein v-aktPhosphorylationPhysical Conditioning, AnimalRatsRats, Sprague-DawleyResveratrolAngiogenesis InhibitorsCarrier ProteinsForkhead Box Protein O3Forkhead Transcription FactorsFOXO3 protein, ratOncogene Protein v-aktPI3KAP protein, ratResveratrolRibonucleotide ReductasesSirt1 protein, ratSirtuin 1Stilbenes

Identifiers

PMID25158994
PMCPMC4453936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.